AWA
HOOK

Authentikos Wealth Advisory’s HOOKIPA Pharma HOOK Stock Holding History

Authentikos Wealth Advisory’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3
Closed -$21 – 266
2023
Q3 		$21 Buy
+3
New +$22 ﹤0.01% 648

Other funds holding HOOK

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Authentikos Wealth Advisory's HOOK Position: Q4 2023 in Review

Authentikos Wealth Advisory sold out of HOOKIPA Pharma (HOOK) in Q4 2023, closing a stake of 3 shares — an estimated $21 sold.

Authentikos Wealth Advisory first reported a position in HOOK in Q3 2023 and held it in 1 quarter. The position peaked at $21 in Q3 2023. 41 funds tracked by Wall St. Rank hold HOOK as of Q4 2023.

  • Authentikos Wealth Advisory reported no remaining HOOKIPA Pharma position as of Q4 2023 after selling out during the quarter.
  • Authentikos Wealth Advisory sold 3 HOOKIPA Pharma shares in Q4 2023, an estimated $21.
  • Authentikos Wealth Advisory first reported a position in HOOKIPA Pharma in Q3 2023 and held it in 1 quarter.
  • Authentikos Wealth Advisory's HOOKIPA Pharma position peaked at $21 in Q3 2023.
  • 41 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q4 2023.

Based on Authentikos Wealth Advisory's 13F filing for Q4 2023, filed 30 Jan 2024.